Tumor Biology

, Volume 33, Issue 5, pp 1281–1290 | Cite as

Differentially expressed proteins identified in overexpressed let-7a gastric carcinoma cells by two-dimensional polyacrylamide gel electrophoresis

  • Yimin Zhu
  • Xingyuan Xiao
  • Lairong Dong
  • Zhiming Liu
Research Article


MicroRNAs are small noncoding RNA molecules that control the expression of target genes. Our previous studies show that let-7a decreased in gastric carcinoma and that up-regulation of let-7a by gene augmentation inhibited gastric carcinoma cell growth both in vitro and in vivo, whereas it remains largely unclear as to how let-7a affects tumor growth. In this study, proteins associated with the function of let-7a were detected in high-throughput screening. The cell line of SGC-7901 stably overexpressing let-7a was successfully established by gene clone. Two-dimensional gel electrophoresis (2-DE) was used to separate the total proteins of SGC-7901/let-7a, SGC-7901/EV and SGC-7901, and PDQuest software was applied to analyze 2-DE images. Ten differential protein spots were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and they may be the proteins associated with let-7a function. The overexpressed proteins include antioxidant protein 2, insulin-like growth factor binding protein 2, protein disulfide isomerase A2, C-1-tetrahydrofolate synthase, cyclin-dependent kinase inhibitor1 (CDKN1) and Rho-GTPase activating protein 4. The underexpressed proteins consisted of S-phase kinase-associated protein 2 (Spk2), platelet membrane glycoprotein, fibronectin and Cks1 protein. Furthermore, the different expression levels of the partial proteins (CDKN1,Spk2 and Fibronectin) were confirmed by Western blot analysis. The data suggest that these differential proteins are involved in novel let-7a signal pathway, and these findings provided the basis to comprehensively investigate the functional mechanisms of let-7a in gastric carcinoma.


Proteomics miRNA Gastric carcinoma 



This work was supported by research grants from the key science and technology projects of Guangxi Zhuang autonomous region China (10124001A-49).

Conflicts of interest



  1. 1.
    Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 200;512: 1753– 61.Google Scholar
  2. 2.
    Zamore PD, Haley B. Ribo-gnome: the big word of small RNAs. Science. 2005;309:1519–24.CrossRefPubMedGoogle Scholar
  3. 3.
    Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.CrossRefPubMedGoogle Scholar
  4. 4.
    Croce CM, Calin GA. microRNA, cancer, stem cell division. Cell. 2005;122:6–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNA modulate hematopoietic lineage differentiation. Science. 2004;303:83–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Didiano D, Hobert O. Perfect seed pairing is not a generally reliable predictor for microRNA–target interactions. Nat Struct Mol Biol. 2006;13:849–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Smalheiser NR, Torvik VI. Complications in mammalian microRNA target prediction. Methods Mol Biol. 2006;342:115–27.PubMedGoogle Scholar
  8. 8.
    Zhu YM, Zhong ZX, Liu ZM. Significance and relationship between let-7a and gastric mucosa cancerization. World J Gastroenterol. 2010;16:3325–29.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Zhu YM, Zhong ZX, Liu ZM. Lentiviral vector-mediated upregulation of let-7a inhibits gastriccarcinoma cell growth in vitro and in vivo. Scand J Gastroenterol. 2011;46:53–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Zhu YM, Liu ZM, Bai WB. Experimental study on the effect of let-7a in cell cycle of human gastric carcinoma cell line. Chin J Exp Surg. 2010;16:424.Google Scholar
  11. 11.
    Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996;13:19–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Sun Y, Yi H, Zhang PF, et al. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett. 2007;581:131–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Zhang B, Metharom P, Jullie H, et al. The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for prediction gene transfer events. Genet Vaccines Ther. 2004;2:6.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Bernard PS, Wittwer CT. Real-time PCR technology for cancer diagnostics. Clin Chem. 2002;48:1178–85.PubMedGoogle Scholar
  15. 15.
    Candiano G, Bruschi M, Musante L. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 2004;25:1327–33.CrossRefPubMedGoogle Scholar
  16. 16.
    Deng C, Zhang P, Harper JW, et al. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995;82:675–84.CrossRefPubMedGoogle Scholar
  17. 17.
    Roninson IB. Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 2002;179:1–14.CrossRefPubMedGoogle Scholar
  18. 18.
    Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of the cell-cycle inhibitor p27Kip1 inhibitor protein: prognostic implications in primary breast cancer. Nat Med. 1997;3:227–30.CrossRefPubMedGoogle Scholar
  19. 19.
    Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cyclin dependent kinase inhibitor p27 in non-small lung cancer. Cancer Res. 1997;57:3382–5.Google Scholar
  20. 20.
    Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis. 2009;12:165–75.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Sitry D, Seeliger MA, Ko TK. Three different binding sites of Cks1 are required for p27-ubiquitin ligation. J Biol Chem. 2002;277:42233–40.CrossRefPubMedGoogle Scholar
  22. 22.
    Erpenbeck L, Schon MP. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood. 2010;115:3427–36.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol. 2005;21:247–69.CrossRefPubMedGoogle Scholar
  24. 24.
    Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol. 2010;11:633–43.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Hoeflich A, Reisinger R, Lahm H. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res. 2001;61:8601–10.PubMedGoogle Scholar
  26. 26.
    Phelan SA. AOP2 (antioxidant protein 2): structure and function of a unique thiol-specific antioxidant. Antioxid Redox Signal. 1999;1:571–84.CrossRefPubMedGoogle Scholar
  27. 27.
    Desilva MG, Lu J, Donadel G. Characterization and chromosomal localization of a new protein disulfide isomerase, PDIp, highly expressed in human pancreas. DNA Cell Biol. 1996;15:9–16.CrossRefPubMedGoogle Scholar
  28. 28.
    Gez S, Crossett B, Christopherson RI. Differentially expressed cytosolic proteins in human leukemia and lymphoma cell lines correlate with lineages and functions. Biochim Biophys Acta. 2007;1774:1173–83.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2012

Authors and Affiliations

  • Yimin Zhu
    • 1
  • Xingyuan Xiao
    • 2
  • Lairong Dong
    • 1
  • Zhiming Liu
    • 3
  1. 1.Department of OncologySecond Hospital of JiaxingJiaxingChina
  2. 2.Department of General SurgeryFirst People’s Hospital of KunshanKunshanChina
  3. 3.Gastrointestine and Gland Surgery DivisionFirst Affiliated Hospital of Guangxi Medical UniversityNanningChina

Personalised recommendations